Inogen (INGN) Competitors $7.24 -0.18 (-2.43%) As of 07/3/2025 03:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INGN vs. CBLL, BBNX, AVNS, EMBC, BVS, RXST, KIDS, AXGN, BFLY, and DCTHShould you be buying Inogen stock or one of its competitors? The main competitors of Inogen include CeriBell (CBLL), Beta Bionics (BBNX), Avanos Medical (AVNS), Embecta (EMBC), Bioventus (BVS), RxSight (RXST), OrthoPediatrics (KIDS), AxoGen (AXGN), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Inogen vs. Its Competitors CeriBell Beta Bionics Avanos Medical Embecta Bioventus RxSight OrthoPediatrics AxoGen Butterfly Network Delcath Systems CeriBell (NASDAQ:CBLL) and Inogen (NASDAQ:INGN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership. Do analysts rate CBLL or INGN? CeriBell presently has a consensus target price of $32.14, indicating a potential upside of 69.84%. Inogen has a consensus target price of $11.00, indicating a potential upside of 51.93%. Given CeriBell's stronger consensus rating and higher probable upside, equities analysts clearly believe CeriBell is more favorable than Inogen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00Inogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media favor CBLL or INGN? In the previous week, Inogen had 1 more articles in the media than CeriBell. MarketBeat recorded 1 mentions for Inogen and 0 mentions for CeriBell. Inogen's average media sentiment score of 0.75 beat CeriBell's score of 0.00 indicating that Inogen is being referred to more favorably in the news media. Company Overall Sentiment CeriBell Neutral Inogen Positive Which has higher valuation and earnings, CBLL or INGN? Inogen has higher revenue and earnings than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBell$65.44M10.45-$40.46MN/AN/AInogen$335.70M0.58-$35.89M-$1.15-6.30 Is CBLL or INGN more profitable? CeriBell has a net margin of 0.00% compared to Inogen's net margin of -8.08%. CeriBell's return on equity of 0.00% beat Inogen's return on equity.Company Net Margins Return on Equity Return on Assets CeriBellN/A N/A N/A Inogen -8.08%-14.76%-9.01% Do insiders & institutionals have more ownership in CBLL or INGN? 89.9% of Inogen shares are owned by institutional investors. 20.1% of CeriBell shares are owned by insiders. Comparatively, 1.5% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryCeriBell beats Inogen on 8 of the 13 factors compared between the two stocks. Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INGN vs. The Competition Export to ExcelMetricInogenMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$201.38M$6.95B$5.56B$9.05BDividend YieldN/A1.21%5.24%4.01%P/E Ratio-6.3026.6327.6120.24Price / Sales0.5898.67416.87118.48Price / CashN/A21.0936.8958.10Price / Book0.994.748.035.67Net Income-$35.89M$173.18M$3.18B$249.21M7 Day Performance2.26%1.33%2.93%3.28%1 Month Performance14.92%0.16%3.75%5.55%1 Year Performance-12.24%23.71%35.20%21.09% Inogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INGNInogen4.4107 of 5 stars$7.24-2.4%$11.00+51.9%-10.4%$201.38M$335.70M-6.301,030CBLLCeriBell2.0954 of 5 stars$18.73-0.9%$32.14+71.6%N/A$676.90M$65.44M0.00N/ABBNXBeta BionicsN/A$14.56-3.4%$23.44+61.0%N/A$631.32M$65.12M0.00294AVNSAvanos MedicalN/A$12.25+0.3%N/A-36.4%$566.44M$687.80M-1.462,227EMBCEmbecta4.1447 of 5 stars$9.69+0.5%$19.33+99.5%-14.5%$566.28M$1.12B10.772,100BVSBioventus2.7088 of 5 stars$6.62-2.2%$14.33+116.5%+21.3%$543.79M$567.70M-10.851,200Positive NewsRXSTRxSight1.7594 of 5 stars$13.00+2.6%$37.90+191.5%-76.8%$528.32M$139.93M-19.40220News CoveragePositive NewsKIDSOrthoPediatrics3.913 of 5 stars$21.48+0.5%$35.83+66.8%-25.0%$521.69M$212.45M-12.27200AXGNAxoGen2.0257 of 5 stars$10.85+3.3%$22.20+104.6%+42.6%$494.11M$187.34M-72.33450Positive NewsHigh Trading VolumeBFLYButterfly Network2.4647 of 5 stars$2.00+1.8%$4.00+100.5%+100.8%$493.34M$82.06M-6.88460News CoverageAnalyst ForecastGap UpDCTHDelcath Systems3.5184 of 5 stars$13.60+0.2%$24.00+76.5%+60.9%$473.69M$37.21M-27.2060Analyst Downgrade Related Companies and Tools Related Companies CeriBell Alternatives Beta Bionics Alternatives Avanos Medical Alternatives Embecta Alternatives Bioventus Alternatives RxSight Alternatives OrthoPediatrics Alternatives AxoGen Alternatives Butterfly Network Alternatives Delcath Systems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INGN) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
